![]() Parkinson’s disease (PD): Parkinson’s disease is a neurodegenerative disorder that causes symptoms like stiffness, slowness, balance and coordination problems, and tremors.For example, studies suggest that people with pyromania may have problems with memory, executive functioning (thinking skills in planning, memory, and self-control), and attention. Brain function: Imaging tests and cognitive assessments have revealed impairments in brain structure, thinking, and cognitive function among people with impulse control disorders.Research indicates that people with kleptomania are more prone to novelty-seeking behaviors (pursuit of new experiences with intense emotional sensations) and are less likely to relate to others. Personality traits: Certain personality traits may make someone more likely to develop an ICD.Certain environmental factors, such as childhood poverty, significantly increase the risk that someone will later be diagnosed with an impulse control disorder. Trauma: Children with impulse control disorders like ODD or CD are significantly more likely than others to have been abused, neglected, harshly punished, or exposed to substance abuse or violence in the home.Meanwhile, twin studies suggest that conduct disorder is passed down in families about 50% of the time. Oppositional defiant disorder, for example, is inherited in approximately 61% of cases. Genetics: Research suggests that genetics plays a role in the development of impulse control disorders.Further studies are needed to confirm these findings. The present findings provide evidence that naltrexone may be effective in the treatment of kleptomania. Five subjects (50.0%) reported previous trials of medication and cognitive-behavioral therapy without any effect on kleptomania symptoms. Nausea was common during the first week of treatment. The mean naltrexone dose required for effective symptom control was 145 mg/day. Men responded to naltrexone as well as women. Subjects also reported overall significant improvement in social and occupational functioning as determined by both the GAF and the SDS (p <. Seven subjects (70.0%) were very much improved and 2 (20.0%) were much improved at study end. 005) over the 11-week treatment period in all measures compared with measures taken at baseline. Subjects showed significant improvement (p <. ![]() Naltrexone reduced urges to steal and stealing behavior. Side effects were monitored weekly, and liver function tests were administered every 2 weeks. Kleptomania symptom change was assessed with the Clinical Global Impressions scale (both severity and improvement measures), Sheehan Disability Scale (SDS), Global Assessment of Functioning (GAF), and Kleptomania Symptom Assessment Scale. The present study was designed to test the short-term efficacy and safety of naltrexone in the treatment of kleptomania.ġ0 subjects (7 women, 3 men) who fulfilled DSM-IV criteria for kleptomania and were free from other Axis I diagnoses by the Structured Clinical Interview for DSM-IV screening participated in a 12-week naltrexone open-label trial.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |